Annaly Capital Management Agrees to Sell Pingora Subsidiary

Annaly Capital Management Agrees to Sell Pingora Subsidiary

Annaly Capital Management Inc, a mortgage real estate investment trust, said late Monday that it has agreed to sell its Pingora Loan Servicing subsidiary to Bayview Asset Management, LLC. Pingora operates as a specialized asset manager focused on investing in new production performing mortgage servicing rights and servicing residential mortgage loans. Terms of the transaction were not disclosed. The transaction is expected to close in Q3, subject to customary closing […]

Read More ˃
Egalet to Raise Funds Via Sale of Shares and Warrants

Egalet to Raise Funds Via Sale of Shares and Warrants

Egalet, a pharmaceutical company, said on Wednesday it is planning to raise funds to market its drugs including morphine sulfate and nasal spray, through the sale of shares and warrants. The drugmaker said the offering is subject to market conditions, with underwriters granted to sell up to 15% additional shares and warrants of securities sold in the offering. Cantor Fitzgerald is the book-runner.

Read More ˃
Asian ADRs Slightly Lower in Trade

Asian ADRs Slightly Lower in Trade

American depository receipts of Asian stocks were trading 0.25% lower at 160.34 on the Bank of New York Mellon Asia ADR Index on Thursday. In North Asia, the gainers were led by semiconductor foundry United Microelectronics (UMC), and Jumei (JMEI), an online retailer of beauty products, which rose 2.2% and 1.8% respectively. They were followed by Autohome (ATHM), an online destination for automobile consumers in China, and media company Phoenix […]

Read More ˃
Minerva Neurosciences Completes Bridging Study

Minerva Neurosciences Completes Bridging Study

Minerva Neurosciences, Inc has concluded a bridging trial to select an improved, gastric-resistant formulation of MIN-101, the company said pre-market Thursday. MIN-101 is a drug candidate designed to improve negative symptoms and cognitive impairment in schizophrenia. The company says it plans to use the selected formulation in its upcoming phase 3 clinical trial, which remains on schedule for initiation in H2, as well as for the potential future submission of […]

Read More ˃
Celsion to Sell Shares in Registered Direct Offering

Celsion to Sell Shares in Registered Direct Offering

Celsion said Monday morning it agreed with several institutional investors to sell an aggregate of approximately 2 million shares of common stock, or pre-funded warrants in lieu thereof, in a registered direct offering at $2.75 per share. Shares were trading more than 22% lower. Additionally, the investors will receive, for each share of common stock or pre-funded warrant purchased in the registered direct offering, a series AAA warrant to purchase […]

Read More ˃
Banc of California Interim CFO Resigns

Banc of California Interim CFO Resigns

Banc of California said Francisco Turner has resigned as interim chief financial officer to pursue other interests. He will receive a lump sum payment of nearly $2.8 million from the company as part of a separation agreement. Chief Accounting Officer Albert Wang will assume the role of principal financial officer as the company continues its search for a permanent CFO with the assistance of Korn Ferry. Wang has been chief […]

Read More ˃
Hilton Prices Shares in Secondary Offering

Hilton Prices Shares in Secondary Offering

Hilton Worldwide Holdings, a global hospitality company, priced a secondary offering of 15 million shares of Hilton common stock by certain selling stockholders affiliated with The Blackstone Group. The offering is expected to close Tuesday, the company said in a press release Thursday. Hilton said it is not offering any shares of common stock in the offering and will not get any proceeds from the sale of shares in this […]

Read More ˃